HealthDay (11/10, Munez) reports, “Getting vaccinated for COVID-19 while pregnant provides higher levels of antibodies for both mom and baby than catching the virus does, a...study finds.” According to the findings published in JAMA Network Open, “when pregnant women received one of the two available mRNA vaccines, researchers found that the women had 10-fold higher antibody concentrations than those who were infected naturally.” The team “detected antibodies as early as 15 days after the women’s first dose of the vaccine.”

Healio (10/6, Bascom) reports that “receiving a COVID-19 vaccine while pregnant did not increase the risk for peripartum outcomes, and may lower the infant’s risk for NICU admission and intrauterine fetal death, according to a” nine-study systematic review and meta-analysis. Investigators “found that, regardless of the timing of the first dose, COVID-19 vaccination was not connected to an increased risk for adverse outcomes in mothers or infants.” The results were published in JAMA Pediatrics.

HealthImaging (9/28, Murphy) reports, “New survey data out of Orlando Health reveals that up to 22% of eligible women have not undergone their first mammographic screening for breast cancer.” Additionally, “according to an Orlando Health release on the data, many of these women (aged 35 to 44) have no intention of completing a breast cancer screening any time soon.”

The Washington Post (9/27, Morris) reports, “A study of nearly 20,000 people around the world shows that getting vaccinated against covid can change the timing of the menstrual cycle. Vaccinated people experienced, on average, about a one-day delay in getting their periods, compared with those who hadn’t been vaccinated.” The data “was taken from a popular period-tracking app called Natural Cycles and included people from around the world, but most were from North America, Britain and Europe.” The findings were published Tuesday in the British Medical Journal.

ACOG’s Practice Advisory “COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care” is now updated to reflect the latest CDC recommendations regarding the use of bivalent (updated) mRNA COVID-19 vaccines as booster doses. All pregnant and recently pregnant people, up to six weeks postpartum, who received a COVID-19 vaccine or vaccine series before or during pregnancy should receive a bivalent (updated) booster at least two months after their last primary series or last monovalent booster dose. Pregnant and recently pregnant individuals aged 12 years and older who already received a monovalent COVID-19 vaccine booster should receive a bivalent mRNA COVID-19 vaccine booster at least two months after their monovalent booster.

Healio (6/29, VanDewater) reports that “coffee consumption during pregnancy was not linked to an increased risk for adverse outcomes, according to” a “two-sample Mendelian randomization...study.” Also, researchers “conducted a one-sample genetic risk score analysis,” which “showed similar results.” These findings were published in the International Journal of Epidemiology.

HealthDay (6/1, Munez) reports a study published in Fertility and Sterility “shows that freezing eggs while younger is a largely successful option for many women who are fertile in their younger years but want to delay pregnancy for a while.” Investigators “looked at success rates of using a woman’s own frozen eggs over 15 years” and “found that about 70% of women who had eggs frozen when they were younger than 38, and thawed at least 20 of those eggs, later had a baby.”

New Zealander Lydia Ko, one of the top ranking golfers in the world, got candid about her period recently during her post-round interview with the LPGA Tour at the Bank of America Palos Verdes Golf Championship.

More Information:
Watch the Interview on Instagram

The GBMC HealthCare app is designed to help patients and their loved ones navigate our healthcare system with ease. It includes GPS wayfinding, directing you from home to the proper parking garage on GBMC's campus. Once you arrive, the app offers step-by-step directions to help you find your exact appointment location.

With the GBMC HealthCare app, you can also access your MyChart account, which allows you to safely

  • make appointments
  • view your medical record
  • request prescriptions
  • view test results
  • communicate securely and electronically with your medical care team
  • pay your bill
  • link your MyChart account with Apple Health via the Track My Health feature

Additionally, the app can be used to find a GBMC HealthCare service or physician that meets your individual needs.

Download the app on the Apple App Store or Google Play.

MedPage Today (3/14, Bassett) reports, “Pelvic floor muscle training using a motion-based digital intravaginal device significantly improved symptoms for women with stress urinary incontinence (SUI) compared with a home training program, a virtually conducted randomized controlled trial showed.” Participants “who used the device had greater improvements in urinary symptom severity and degree of bother as measured by the Urogenital Distress Inventory, Short Form (UDI-6) score versus the control group.” The findings were published in Obstetrics & Gynecology.

Capital Women's Care - Division 56 is able to prescribe these digital devices! Schedule an in-person or virtual visit for a consultation if interested.

The New York Times (2/15, Anthes) reports infants born to mothers who “received two doses of an mRNA coronavirus vaccine during pregnancy are less likely to be admitted to the hospital for Covid-19 in the first six months of life, according to a new study from the Centers for Disease Control and Prevention.” The study found that “overall, maternal vaccination was 61 percent effective at preventing infant hospitalization.”

Reuters (2/15, Mishra, Steenhuysen) reports, “That protection rose to 80% when the mothers were vaccinated 21 weeks through 14 days before delivery.” Meanwhile, the “effectiveness fell to 32% for the babies whose mothers were inoculated earlier during pregnancy.”

The Hill (2/15, Sullivan) reports the study used data “from 20 pediatric hospitals in 17 states, from July 2021 to January 2022.”

The Wall Street Journal (2/15, Toy, Subscription Publication) also reports on the study.

The New York Times (2/12, Hassan) reported two studies “lay out the added difficulties that unvaccinated women with Covid have during pregnancy and childbirth, adding to research showing that they face elevated risks.” The first study, published “in the Archives of Pathology & Laboratory Medicine, suggests that the coronavirus can invade and destroy the placenta, through which the mother passes nutrients to the fetus.” The second, published in JAMA, “found that pregnant women infected with the coronavirus are about 40 percent more likely to develop serious complications or die during pregnancy than those who aren’t infected.”

CNN (1/20, Howard) reports a study published in the American Journal of Epidemiology “adds to growing evidence that there is no connection between Covid-19 vaccinations and a reduced chance of conceiving a baby.” Instead, “couples in the study had slightly lower chances of conception if the male partner had been infected with the coronavirus within 60 days – which offers even more reason to get vaccinated against Covid-19, since the illness could affect male fertility in the short term, according to the study.”

Bloomberg Law (1/20, Baumann, Subscription Publication) reports, “Data from tens of thousands of individuals indicate the vaccines are safe for pregnancy and can even build and pass antibodies along to the baby, according to the American College of Obstetricians and Gynecologists.” ACOG and the CDC “have both recommended Covid-19 shots for anyone who’s pregnant or trying to become pregnant.”

MedPage Today (1/20, D'Ambrosio) also reports on the study.

Reuters (1/18, Aripaka) reports mRNA COVID-19 vaccines “do not cause pregnancy complications for expectant mothers and their babies, the European Union’s drug regulator said on Tuesday.” A “review based on studies involving around 65,000 pregnancies at different stages did not find any sign of higher risk of complications, miscarriages, preterm births or severe side-effects on the fetuses from mRNA shots,” the European Medicines Agency said.

Healio (1/12, Stulpin) reports a study has “found that SARS-CoV-2 infection during pregnancy is associated with an increased risk for adverse pregnancy outcomes” including “cesarean sections, preterm birth and fetal growth restriction.” The national cohort study published in the Journal of Infectious Diseases used “de-identified administrative claims data for 78,283 pregnancies” and found that infection was also tied to a greater risk for postpartum hemorrhage, “but was not associated with risk for miscarriage, antepartum hemorrhage or stillbirth.”

The New York Times (1/6, Rabin) reports, “Shortly after coronavirus vaccines were rolled out about a year ago, women started reporting erratic menstrual cycles after receiving the shots.” And now, “a study published on Thursday found that women’s menstrual cycles did indeed change following vaccination against the coronavirus.” Researchers “reported that women who were inoculated had slightly longer menstrual cycles after receiving the vaccine than those who were not vaccinated.” The findings were published in the journal Obstetrics & Gynecology.

The AP (1/6, Neergaard) reports the research “tracked nearly 4,000 U.S. women through six menstrual cycles and on average, the next period after a shot started about a day later than usual,” although “there was no change in the number of days of menstrual bleeding after COVID-19 vaccination.” In a statement, Dr. Christopher Zahn of the American College of Obstetricians and Gynecologists said that the findings provide “important new evidence underscoring that any impact of the COVID vaccines on menstruation is both minimal and temporary.”

Also reporting are NPR (1/6, Brumfiel), CNN (1/6, McPhillips) and The Lily (1/6, McShane).

The New York Times (1/4, Rabin) reports “women who received Covid vaccinations while pregnant were at no greater risk of” preterm births or small-for-gestational age births, according to a Centers for Disease Control and Prevention study that “looked at some 46,079 singleton pregnancies that resulted in a live birth, including some 10,064 among women who received one or more doses of Covid vaccine between Dec. 15, 2020, and July 22, 2021, during their pregnancies.” Overall, the study found that “6.6 percent of the babies were born prematurely, before 37 weeks of pregnancy, and 8.2 percent were born small for their gestational age, weighing less than 5 pounds and 8 ounces.”

The Hill (1/4, Coleman) reports the study “found there were 4.9 preterm births, occurring before 37 weeks’ gestation, per 100 live births among vaccinated pregnant women,” while “preterm births reached seven per 100 live births” among unvaccinated pregnant women. There were no differences in SGA births among both groups.


Healio (12/14, Gawel) reports, “Women who live around more green space throughout their lives are less likely to experience PMS symptoms than women living in areas that are less green, according to a study” that also found they “were less likely to experience anxiety,” depression, difficulty sleeping, “and breast tenderness or abdominal bloating.” For the study, published in Environment International, investigators “gathered data between 2013 and 2015 from 1,069 women aged 18 to 49 years...participating in the multicenter, population-based European RHINESSA cohort.”

Healio (12/9, VanDewater) reports that a retrospective cohort study “found that pregnant patients who were vaccinated against SARS-CoV-2 were less likely to have severe COVID-19 or any severity of the disease in the context of the delta variant surge.” The findings were published in Obstetrics & Gynecology.

Reuters (12/6, Brooks) reports, “Radiologists observed significant changes in the brain structure of fetuses exposed to alcohol in the first MRI-based study to investigate the issue.” The findings were presented at the annual meeting of the Radiological Society of North America.